Aptose Biosciences Announces Completion of Acquisition by Hanmi Pharmaceutical | APTOF Stock NewsStockTitan·Jun 30 at 10:32 AMAPTOF0.00%
Aptose Presents 86% CRc and 86% MRD-negativity in TUSCANY AML Triplet TrialTradingView·Jun 15 at 07:03 AMAPTOF0.00%
Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical | APTOF Stock NewsStockTitan·May 28 at 10:30 PMAPTOF0.00%
Aptori Launches Autonomous Offensive Testing to Eliminate the AI-Driven Security BacklogUnusual Whales·Apr 26 at 08:41 PMAPTO0.00%APTOF0.00%
Aptose Shareholders Approve Hanmi Acquisition and Re-DomicilingTip Ranks·Mar 31 at 10:33 PMVHT+1.16%LABU+2.48%
Aptose Biosciences 10-K: No Revenue, Net Loss $(25.468) M, EPS $(10.41)TradingView·Mar 31 at 04:35 PMAPTO0.00%IBB+0.87%
Alligator Bioscience Updates Share Count After Warrant ExerciseTip Ranks·Mar 31 at 11:02 AMXBI+0.74%PBE+0.17%
Aptose Biosciences Announces Results of Special Shareholders Meeting; Announces Receipt of Final Court Approval of Plan of Arrangement; Reports Year End 2025 Results and Corporate Highlights | APTOF Stock NewsStockTitan·Mar 31 at 08:22 AMIHE+1.21%FBT+0.76%
